Gilad Rosenberg

Dr. Gilad Rosenberg, MD, MSc has a vast and diverse work experience. Starting as a Resident in the Neurology Department at Hadassah Medical Center in 1994, they then progressed to various Medical Director roles at Promedico, Merck Israel, D-Pharm Ltd., and Clal Biotechnology Industries. Gilad advanced to Vice President of Clinical Development at D-Pharm Ltd., before taking on the position of Executive Medical Director and Therapeutic Lead in Neuroscience at Allucent in 2021.

Dr. Gilad Rosenberg completed their Doctor of Medicine (MD) with Cum Laude honors from Technion - Israel Institute of Technology in the field of Medicine from 1984 to 1991. Gilad later pursued a Master of Science (MSc) in Neuroscience at the University of Oxford from 2004 to 2005. Dr. Rosenberg also obtained a certification as a member of the American Academy of Neurology in 2007.